导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 7.65% | 337/1050 |
| 近一周 | -3.18% | 829/1104 |
| 近一月 | -4.14% | 519/1102 |
| 近一季 | -6.20% | 473/1092 |
| 近半年 | -5.59% | 635/1070 |
| 近一年 | 5.59% | 456/1018 |
| 近两年 | 75.38% | 328/926 |
| 近三年 | 35.65% | 346/834 |
| 成立以来 | 77.92% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
7.85% 68/1070 |
9.16% 557/1101 |
- - |
- - |
| 2025 | 24.64% 586/1065 |
-1.04% 860/1014 |
1.69% 538/1038 |
33.77% 302/1050 |
-7.41% 816/1065 |
| 2024 | 5.56% 408/1011 |
-13.45% 876/960 |
2.14% 191/983 |
15.52% 202/991 |
3.36% 187/1011 |
| 2023 | -14.93% 519/952 |
10.74% 98/880 |
-9.96% 768/895 |
-13.12% 732/915 |
-1.81% 217/952 |
| 2022 | -23.61% 453/867 |
-5.28% 37/773 |
-3.44% 743/806 |
-14.86% 553/845 |
-1.90% 534/867 |
| 2021 | 22.38% 142/740 |
-2.10% 227/580 |
1.25% 528/659 |
11.56% 48/704 |
10.67% 65/740 |
| 2020 | 49.14% 240/554 |
2.31% 108/419 |
13.55% 370/466 |
14.24% 157/517 |
12.38% 275/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 湘财长源股票型A VS. 东吴新产业精选股票A(580008) |